[Treatment and progression management of acute kidney injury]

Area of Science:

• Nephrology
• Translational Medicine
• Biomedical Engineering

Background:

• Acute kidney injury (AKI) poses a significant global health challenge, characterized by high mortality rates.
• The complex etiology and pathophysiology of AKI have hindered the development of effective causal treatments.
• Current management focuses on supportive care, including avoiding nephrotoxicity and optimizing hemodynamics per KDIGO guidelines.

Purpose of the Study:

• To review current understanding and management of acute kidney injury.
• To explore emerging therapeutic avenues for AKI.
• To highlight the critical post-AKI phase for disease progression.

Main Methods:

• Literature review of current AKI research and clinical guidelines.
• Analysis of recent advancements in understanding AKI pathogenesis.
• Exploration of novel therapeutic strategies, including nanotechnology.

Main Results:

• AKI treatment requires stage-adapted care following KDIGO guidelines.
• Mitochondrial dysfunction and cellular senescence are key factors in AKI.
• Nanotechnology offers potential for targeted drug delivery in future AKI therapies.

Conclusions:

• Effective AKI management necessitates adherence to current guidelines and vigilant monitoring.
• Emerging research into cellular mechanisms and nanotechnology holds promise for future targeted AKI therapies.
• The weeks following an AKI event are critical for managing disease progression and patient outcomes.